277 related articles for article (PubMed ID: 16121702)
1. Vaccinia virus and oncolytic virotherapy of cancer.
Thorne SH; Hwang TH; Kirn DH
Curr Opin Mol Ther; 2005 Aug; 7(4):359-65. PubMed ID: 16121702
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic vaccinia virus: from bedside to benchtop and back.
Thorne SH
Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
[TBL] [Abstract][Full Text] [Related]
3. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
4. Fighting cancer with vaccinia virus: teaching new tricks to an old dog.
Shen Y; Nemunaitis J
Mol Ther; 2005 Feb; 11(2):180-95. PubMed ID: 15668130
[TBL] [Abstract][Full Text] [Related]
5. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
Thorne SH; Contag CH
Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
[TBL] [Abstract][Full Text] [Related]
6. Next-generation oncolytic vaccinia vectors.
Thorne SH
Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
[TBL] [Abstract][Full Text] [Related]
7. Design and testing of novel oncolytic vaccinia strains.
Thorne SH
Methods Mol Biol; 2009; 542():635-47. PubMed ID: 19565925
[TBL] [Abstract][Full Text] [Related]
8. Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus.
Thorne SH; Kirn DH
Expert Opin Biol Ther; 2004 Aug; 4(8):1307-21. PubMed ID: 15268664
[TBL] [Abstract][Full Text] [Related]
9. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Bauzon M; Hermiston TW
Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
[TBL] [Abstract][Full Text] [Related]
10. [Oncolytic viruses for genetic therapy of gastrointestinal tumors].
Bitzer M; Lauer UM
Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239
[TBL] [Abstract][Full Text] [Related]
11. Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors.
Mastrangelo MJ; Lattime EC
Cancer Gene Ther; 2002 Dec; 9(12):1013-21. PubMed ID: 12522440
[TBL] [Abstract][Full Text] [Related]
12. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
13. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
Hermiston TW; Kuhn I
Cancer Gene Ther; 2002 Dec; 9(12):1022-35. PubMed ID: 12522441
[TBL] [Abstract][Full Text] [Related]
14. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
[TBL] [Abstract][Full Text] [Related]
15. Replication-selective oncolytic viruses in the treatment of cancer.
Everts B; van der Poel HG
Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
[TBL] [Abstract][Full Text] [Related]
16. Advances in oncolytic viral therapy.
Woo Y; Adusumilli PS; Fong Y
Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
Thorne SH; Hermiston T; Kirn D
Semin Oncol; 2005 Dec; 32(6):537-48. PubMed ID: 16338419
[TBL] [Abstract][Full Text] [Related]
18. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes.
Pühler F; Willuda J; Puhlmann J; Mumberg D; Römer-Oberdörfer A; Beier R
Gene Ther; 2008 Mar; 15(5):371-83. PubMed ID: 18200068
[TBL] [Abstract][Full Text] [Related]
19. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
20. Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.
Zeh HJ; Bartlett DL
Cancer Gene Ther; 2002 Dec; 9(12):1001-12. PubMed ID: 12522439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
